Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shionogi of Japan to Take Control of China’s C&O Pharma

publication date: Aug 1, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shionogi & Co., a Japanese pharma, will pay $185 million to obtain a controlling interest in C&O Pharmaceutical Technology. C&O Pharma, a company that produces antibiotics and other drugs for the China market, is headquartered in Hong Kong, but listed in Singapore. Shionogi said it wants to establish a major presence in China for its own drugs. More details....

Stock Symbol: (TO: 8053)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners